Browse by Phase
Phase 1 / Phase 2 Clinical Trials
Phase 1/2 combined trials evaluate both safety (Phase 1) and preliminary efficacy (Phase 2) in a single study protocol, often used to accelerate early development.
Total Trials
360
Recruiting Now
360
Top Conditions in Phase 1 / Phase 2
NCT04776330 Phase 1, Phase 2
Recruiting
a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refrac...
Condition
Multiple Myeloma
Enrollment
80 pts
Location
China
Sponsor
Chongqing Precision Biotech Co
NCT05949944 Phase 1, Phase 2
Recruiting
Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell L...
Condition
Peripheral T-cell Lymphoma
Enrollment
50 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06961071 Phase 1, Phase 2
Recruiting
Parathyroid Allotransplant for Treatment of Hypoparathyroidism
Condition
Hypoparathyroidism
Enrollment
3 pts
Location
United States
Sponsor
Peter Stock
NCT03965234 Phase 1, Phase 2
Recruiting
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sar...
Condition
Metastatic Bone Sarcoma
Enrollment
99 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT05098132 Phase 1, Phase 2
Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung ...
Condition
Advanced Solid Tumor
Enrollment
364 pts
Location
United States
Sponsor
Synthekine
NCT06132711 Phase 1, Phase 2
Recruiting
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multip...
Condition
Multiple Myeloma
Enrollment
20 pts
Location
China
Sponsor
Xuzhou Medical University
NCT02584244 Phase 1, Phase 2
Recruiting
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Condition
Colorectal Cancer
Enrollment
66 pts
Location
United States
Sponsor
Lumicell, Inc.
NCT05270200 Phase 1, Phase 2
Recruiting
Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of ...
Condition
Leukemia, Myeloid, Acute
Enrollment
20 pts
Location
China
Sponsor
Zhujiang Hospital
NCT05586581 Phase 1, Phase 2
Recruiting
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis D...
Condition
HIV Associated Neurocognitive Disorder
Enrollment
70 pts
Location
United States
Sponsor
Yale University
NCT05319730 Phase 1, Phase 2
Recruiting
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-347...
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
230 pts
Location
United States, Brazil, Chile
Sponsor
Merck Sharp & Dohme LLC
NCT06631092 Phase 1, Phase 2
Recruiting
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Trip...
Condition
Triple Negative Breast Cancer
Enrollment
12 pts
Location
Germany
Sponsor
NEC Bio B.V
NCT06532812 Phase 1, Phase 2
Recruiting
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refracto...
Condition
Breast Cancer
Enrollment
85 pts
Location
China
Sponsor
Essen Biotech
NCT06290258 Phase 1, Phase 2
Recruiting
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Condition
Autism Spectrum Disorder
Enrollment
60 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07392736 Phase 1, Phase 2
Recruiting
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Adva...
Condition
Solid Tumor
Enrollment
228 pts
Location
China
Sponsor
Advenchen Laboratories, LLC
NCT05329636 Phase 1, Phase 2
Recruiting
Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
Condition
Helicobacter Pylori Infection
Enrollment
30 pts
Location
Israel
Sponsor
Tel-Aviv Sourasky Medical Cent
NCT05655182 Phase 1, Phase 2
Recruiting
A Study of BLB-201 RSV Vaccine in Infants and Children
Condition
Respiratory Syncytial Virus Infections
Enrollment
137 pts
Location
United States
Sponsor
Blue Lake Biotechnology Inc.
NCT06721962 Phase 1, Phase 2
Recruiting
Treatment of Moderate to Severe Refractory Crohn's Disease
Condition
Crohns Disease
Enrollment
39 pts
Location
United States
Sponsor
Tr1X, Inc.
NCT03128996 Phase 1, Phase 2
Recruiting
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant...
Condition
Severe Sickle Cell Disease
Enrollment
29 pts
Location
United States
Sponsor
Washington University School o
NCT06108063 Phase 1, Phase 2
Recruiting
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
Condition
Knee Arthroplasty, Total
Enrollment
120 pts
Location
United States
Sponsor
Steadman Philippon Research In
NCT06125652 Phase 1, Phase 2
Recruiting
Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory...
Condition
Acute Myeloid Leukemia Refractory
Enrollment
20 pts
Location
China
Sponsor
Xuzhou Medical University
NCT06970145 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Condition
Craniopharyngiomas
Enrollment
57 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med
NCT05785741 Phase 1, Phase 2
Recruiting
A Phase 1/2a Study of DB-1310 in Advanced/Metastatic Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
1,000 pts
Location
United States, China
Sponsor
DualityBio Inc.
NCT07242222 Phase 1, Phase 2
Recruiting
Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Condition
Fatty Liver
Enrollment
50 pts
Location
Egypt
Sponsor
Tanta University
NCT06617793 Phase 1, Phase 2
Recruiting
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB...
Condition
Relapsing Multiple Sclerosis
Enrollment
28 pts
Location
Australia, France, Germany
Sponsor
Novartis Pharmaceuticals
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu...
Condition
Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canada, France
Sponsor
Marengo Therapeutics, Inc.